Skip to main content
Year archive

SinoMab BioScience Limited — 2025 filings

All 50 regulatory filings released by SinoMab BioScience Limited (3681) in 2025, sourced directly from the official regulator.

50 Filings
2025 Period
2025 filings (50)
Filing Released Lang
VOLUNTARY ANNOUNCEMENT IND APPLICATION FOR SM17 ACCEPTED BY NMPA CDE
Regulatory Filings
2025-12-11 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2025
Regulatory Filings
2025-12-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2025
Regulatory Filings
2025-11-05 English
VOLUNTARY ANNOUNCEMENT FIRST COHORT OF HEALTHY SUBJECTS DOSED WITH SUBCUTANEOUS FORMULATION OF SM17 IN A BRIDGING STUDY IN CHINA
Regulatory Filings
2025-10-14 English
CHANGE OF COMPANY SECRETARY
Board/Management Information
2025-10-08 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2025
Regulatory Filings
2025-10-06 English
Notification Letter to Non-registered Shareholders and Reply Form
Report Publication Announcement
2025-09-26 English
Notification Letter to Registered Shareholders and Reply Form
Report Publication Announcement
2025-09-26 English
Interim Report 2025
Interim / Quarterly Report H1 2025
2025-09-26 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2025
Share Issue/Capital Change
2025-09-04 English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2025
Interim / Quarterly Report H1 2025
2025-08-29 English
Next Day Disclosure Return
Share Issue/Capital Change
2025-08-29 English
COMPLETION OF SUBSCRIPTIONS OF NEW SHARES UNDER GENERAL MANDATE
Share Issue/Capital Change
2025-08-29 English
DATE OF BOARD MEETING
Report Publication Announcement
2025-08-18 English
Next Day Disclosure Return
Share Issue/Capital Change
2025-08-15 English
COMPLETION OF CERTAIN SUBSCRIPTIONS OF NEW SHARES UNDER GENERAL MANDATE
Share Issue/Capital Change
2025-08-15 English
VOLUNTARY ANNOUNCEMENT COMPREHENSIVE STRATEGIC COOPERATION AGREEMENT
Regulatory Filings
2025-08-12 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2025
Regulatory Filings
2025-08-05 English
GRANT OF SHARE OPTIONS
Share Issue/Capital Change
2025-07-24 English
SUBSCRIPTIONS OF NEW SHARES UNDER GENERAL MANDATE
Share Issue/Capital Change
2025-07-22 English
INSIDE INFORMATION UPDATE ON THE BLA FOR SM03 (SUCIRASLIMAB) IN THE TREATMENT OF RHEUMATOID ARTHRITIS
Regulatory Filings
2025-07-14 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2025
Regulatory Filings
2025-07-07 English
TERMS OF REFERENCE OF THE NOMINATION COMMITTEE ADOPTED BY THE BOARD ON 30 JUNE, 2025
Governance Information
2025-06-30 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information
2025-06-30 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 30 JUNE 2025, APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTORS, CHANGE IN COMPOSITION OF BOARD COMMITTEES AND RE-COMPLIANCE WITH RULE 3.27A OF THE
Declaration of Voting Results & Voting Rights Announcements
2025-06-30 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Governance Information
2025-06-12 English
RESIGNATION OF EXECUTIVE DIRECTOR
Board/Management Information
2025-06-12 English
POSTPONEMENT AND CHANGE OF VENUE OF ANNUAL GENERAL MEETING AND CHANGE OF BOOK CLOSURE PERIOD
Regulatory Filings
2025-06-11 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Governance Information
2025-06-09 English
PASSING AWAY OF AN INDEPENDENT NON-EXECUTIVE DIRECTOR AND WITHDRAWAL OF ORDINARY RESOLUTION NO. 2(d) AT THE ANNUAL GENERAL MEETING
Board/Management Information
2025-06-09 English
VOLUNTARY ANNOUNCEMENT CESSATION TO ACT AS PRESIDENT (CHINA)
Board/Management Information
2025-06-06 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2025
Regulatory Filings
2025-06-05 English
Next Day Disclosure Return
Share Issue/Capital Change
2025-05-29 English
COMPLETION OF SUBSCRIPTIONS OF NEW SHARES UNDER GENERAL MANDATE
Share Issue/Capital Change
2025-05-29 English
SUBSCRIPTIONS OF NEW SHARES UNDER GENERAL MANDATE
Share Issue/Capital Change
2025-05-13 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2025
Regulatory Filings
2025-05-07 English
2024 Environmental, Social and Governance Report
Environmental & Social Information
2025-04-24 English
Notification Letter to Non-registered Shareholders and Reply Form
Report Publication Announcement
2025-04-24 English
Notification Letter to Registered Shareholders and Reply Form
Report Publication Announcement
2025-04-24 English
NOTICE OF 2025 ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement
2025-04-24 English
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD AT ROOM 3, 14/F, FAIRMONT HOUSE, 8 COTTON TREE DRIVE, CENTRAL, HONG KONG ON FRIDAY, 13 JUNE 2025 AT 10:00 A.M.
Proxy Solicitation & Information Statement
2025-04-24 English
PROPOSED RE-ELECTION OF RETIRING DIRECTORS AND PROPOSED GRANTING OF GENERAL MANDATES TO BUY BACK SHARES AND TO ISSUE SHARES AND NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement
2025-04-24 English
Annual Report 2024
Regulatory Filings
2025-04-24 English
INSIDE INFORMATION POSITIVE TOPLINE RESULTS FROM PHASE 1B CLINICAL TRIAL OF SM17 IN CHINA FOR THE TREATMENT OF MODERATE-TO-SEVERE ATOPIC DERMATITIS
Regulatory Filings
2025-04-07 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2025
Regulatory Filings
2025-04-03 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2024&#x3b; AND CHANGE IN USE OF PROCEEDS
Earnings Release FY 2024
2025-03-31 English
DATE OF BOARD MEETING
Regulatory Filings
2025-03-19 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2025
Regulatory Filings
2025-03-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2025
Share Issue/Capital Change
2025-02-06 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2024
Regulatory Filings
2025-01-07 English